Cannabis Science Issues Earnings Guidance for 2012 forecasted at $6, 846, 000 and potential increased to $65, 740, 000 in 2014 with $0.02 per share positive earnings

Cannabis Science, Inc. (OTCBB: CBIS), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to issue Sales Guidance and Outlook for 2012. There are three main markets for Cannabis Science Brand formulations for distribution, FDA approved prescriptions, OTC Non-psychoactive Neutroceuticals, and licensed dispensaries in legal Medical Marijuana states (currently 16). Cannabis Science sales for 2012 are forecasted to be $6,846,000 and has the potential to increase to $65,...continued CBIS

URL: http://www.investorpoint.com/news/INVESTOP/47187019/